Results 141 to 150 of about 1,376,841 (287)
Analysis of Implicit Communication of Motorists and Cyclists in Intersection Using Video and Trajectory Data. [PDF]
Front Psychol, 2022 Zhang M, Dotzauer M, Schießl C.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
TrPLS: Preserving Privacy in Trajectory Data Publishing by Personalized Local Suppression
International Journal of Information and Communication Technology Research, 2014 Trajectory data are becoming more popular due to the rapid development of mobile devices and the widespread use of location-based services. They often provide useful information that can be used for data mining tasks.
Elahe Ghasemi Komishani, Mahdi Abadi
doaj
Estimation of Spatial-Temporal Distribution of Grazing Intensity Based on Sheep Trajectory Data. [PDF]
Sensors (Basel), 2022 Fan X, Xuan C, Zhang M, Ma Y, Meng Y.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
The Design and Development of a Ship Trajectory Data Management and Analysis System Based on AIS. [PDF]
Sensors (Basel), 2021 Feng C, Fu B, Luo Y, Li H.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Using Connected Vehicle Trajectory Data to Evaluate the Impact of Automated Work Zone Speed Enforcement. [PDF]
Sensors (Basel), 2022 Mathew JK +3 more
europepmc +1 more source
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz +8 more
wiley +1 more source
Modelling imperfect knowledge via location semantics for realistic privacy risks estimation in trajectory data. [PDF]
Sci Rep, 2022 Bennati S, Kovacevic A.
europepmc +1 more source